Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway
Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway
复制标题
DOI:
10.1074/jbc.m500168200
复制
发表时间:
2005-07-08
影响因子:
4.8
通讯作者:
Kudo, I
中科院分区:
文献类型:
--
作者:
Kuwata, H;Nonaka, T;Kudo, I
Inducible expression of group IIA secretory phospholipase A(2) ( sPLA(2)- IIA) by interleukin- 1 beta( IL- 1 beta) and tumor necrosis factor- alpha( TNF alpha) is under the control of group IVA cytosolic PLA(2)alpha and 12/ 15- lipoxygenase ( 12/ 15- LOX) in rat fibroblastic 3Y1 cells. We show here that this cytokine induction of sPLA2- IIA mRNA requires de novo protein synthesis. By means of cDNA array analysis, we found that the level of the CXC chemokine MIP- 2 ( macrophage inflammatory protein- 2) was significantly elevated in 12/ 15- LOX- transfected cells compared with control cells. IL-1 beta/ TNF alpha- stimulated induction of endogenous MIP- 2 preceded that of sPLA2- IIA, and exogenous MIP- 2 induced sPLA2- IIA dose- dependently. Moreover, a MIP- 2- specific antisense oligonucleotide and small interfering RNA attenuated the IL- 1 beta/ TNF alpha- induced expression of sPLA(2)-IIA, suggesting that MIP- 2 is an absolute intermediate requirement for optimal induction of sPLA2- IIA. In addition, the expression of c- jun and fra- 1, which are components of the transcription factor AP- 1, was elevated in 12/ 15- LOX- transfected cells, in which cytokine- dependent binding of AP- 1 to the sPLA2- IIA promoter was increased significantly. Conversely, the receptors for transforming growth factor-beta and platelet- derived growth factor, which contributed to down- regulation of sPLA2- IIA expression, were decreased following 12/ 15- LOX overexpression. Taken together, 12/ 15- LOX- dependent up- regulation of sPLA2- IIA expression may result from the interplay between accelerated MIP- 2 signaling, AP- 1 activation, and attenuated transforming growth factor-beta and platelet- derived growth factor signaling.